Why AbbVie Could Join the M&A Mania Soon Post author:Sam Post published:January 30, 2018 Post category:BioPharma The company expects to only pay a tax rate of 9 percent this year, which will free up a lot of cash. Source: BioSpace You Might Also Like Eleven Bio Reports Fourth Quarter And Full Year 2016 Financial Results March 23, 2017 3 Biotech Stocks That Look Like Apple Did in the 1980s June 21, 2017 Where High-Flying Cara Therapeutics Could be in 5 Years October 5, 2017